LifeTech Scientific (HKG:1302) said Ankura Aortic Stent Graft System received official registration approval
from the China National Medical Products Administration (NMPA), according to a Wednesday filing with the Hong Kong bourse.
The system was jointly developed by Professor Shu Chang of Fuwai Hospital, Chinese Academy of Medical Sciences, and the Group. The system is an aortic stent graft system designed for the chimney technique, offering an effective treatment for aortic arch lesions with broad anatomical compatibility.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。